Tampa, FL, United States of America

Archie A Silver

USPTO Granted Patents = 7 

Average Co-Inventor Count = 3.7

ph-index = 4

Forward Citations = 79(Granted Patents)


Company Filing History:


Years Active: 2000-2019

Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Archie A. Silver

Introduction

Archie A. Silver is a notable inventor based in Tampa, FL, who has made significant contributions to the field of pharmaceuticals. With a total of 7 patents to his name, Silver's work focuses on innovative treatments for various medical conditions.

Latest Patents

One of Silver's latest patents is the formulation and use of exo-S-mecamylamine in treatment. This pharmaceutical composition includes a therapeutically effective amount of exo-S-mecamylamine or a pharmaceutically acceptable salt thereof, which is substantially free of exo-R-mecamylamine. The formulation is designed to treat a range of medical conditions, including substance addiction, smoking cessation, hypertension, Tourette's Syndrome, cancer, neuropsychiatric disorders, chronic fatigue syndrome, and more. The recommended dosage ranges from about 0.5 mg to about 20 mg, depending on the specific medical condition being addressed.

Career Highlights

Throughout his career, Archie A. Silver has worked with esteemed institutions such as the University of South Florida and Targacept, Inc. His research and innovations have contributed to advancements in the treatment of complex medical issues, showcasing his dedication to improving patient outcomes.

Collaborations

Silver has collaborated with notable colleagues, including Paul R. Sanberg and Douglas Shytle. These partnerships have further enhanced his research efforts and expanded the impact of his inventions.

Conclusion

Archie A. Silver's innovative work in pharmaceuticals, particularly with exo-S-mecamylamine, highlights his commitment to addressing significant medical challenges. His contributions continue to influence the field and improve the lives of many individuals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…